Dr. Peter McKenna:

Correct. As Mr. McCallion has said, there are reasons different laboratories could have identified different expected rates of invasive cancer. Getting back to Deputy Durkan's question, I understand that every laboratory appears to have had a number of interval cancers and no laboratory stands out as having none. That would need to be confirmed, but initial inquiries suggest that no particular laboratory has any very obvious issues with regard to identifying interval cancers.